NCsoft Corp (036570)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 198,700.00 |
|---|---|
| 52-week range | 176,100.00 – 343,500.00 |
| Return, 1 month / 3 months | −6.3% / −14.5% |
| Return, 1 year / 3 years | −6.2% / −11.4% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 58.2% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 21,479.63M KRW |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NCsoft Corp is a South Korean developer and publisher of online computer games, based in the city of Seongnam. The company is known for its long-running Lineage series of massively multiplayer online role-playing games, which are played by subscribers in Korea and across Asia. It also develops and publishes other online role-playing titles for personal computer players, and it operates the game services and online storefronts through which its customers play them.
The shares are listed on the Korea Exchange in Korea under the code 036570, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NCsoft Corp (036570) trades on the Korea Exchange in Korea. It last closed at KRW 198,700.00 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 441 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.2% and over the last three months it fell 14.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.3% | ||
| From 52-week high | -41.2% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.5% | ||
| 6-month return | -24.0% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 21,479.63M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.9% |
|---|---|
| 1 month | −6.3% |
| 3 months | −14.5% |
| 6 months | −24.0% |
| 1 year | −6.2% |
| 3 years | −11.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 217,614.00 / 234,555.85 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10,379.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 1,150.0000 |
| 21 Mar 2025 | KRW 1,460.0000 |
| 27 Dec 2023 | KRW 3,130.0000 |
| 28 Dec 2022 | KRW 6,680.0000 |
| 29 Dec 2021 | KRW 5,860.0000 |
| 29 Dec 2020 | KRW 8,550.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.